Amalya Sargsyan: New ESO Rare Cancer Series podcast with Salvatore Provenzano
Amalya Sargsyan, Medical Oncologist at Yeolyan Center, shared a post on LinkedIn:
“New Podcast Alert.
Want a quick overview of angiosarcomas?
Check out our new European School of Oncology Rare Cancer Series podcast with Dr. Salvatore Provenzano. From histology and diagnosis to treatment and future directions – you’ll get an expert’s perspective on essentials in just a few minutes.
Find it on the e-ESO platforms:
Spotify, Apple Podcasts, Google Podcasts, and the ESO website.”
More posts featuring Amalya Sargsyan.
Dr. Amalya Sargsyan is a Medical Oncologist at Yeolyan Center, a Research Physician at the Immune Oncology Research Institute, and Senior Editor at Oncodaily. She holds an MD from Yerevan State Medical University and an MSc in Precision Medicine from the University of Cyprus.
Dr. Sargsyan completed her clinical training at the Bank of Cyprus Oncology Center and has been honored with an ASCO IDEA award. Her research focuses on the potential of novel immune checkpoint inhibitors (ICI) in low- and middle-income countries (LMICs), aiming to bridge disparities and enhance access to innovative cancer care.
Salvatore Provenzano is a Medical Oncologist at the Foundation IRCCS National Cancer Institute in Milan, Italy. He specializes in the treatment of soft tissue and bone sarcomas, as well as other rare cancers, with expertise honed through advanced post-graduate training.
Currently, he is working on clinical and translational research in a referral adult mesenchymal tumours at the Medical Oncology Unit.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023